GSA Capital Partners »

Compass Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $121k 66k 1.84
2024-06-30 $66k 66k 1.00

More positions owned by GSA Capital Partners

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Global Ship Lease Com Cl A (GSL)
Staar Surgical Com Par $0.01 (STAA)
Progressive Corporation (PGR)
Accenture Plc Ireland Shs Class A (ACN)
Star Bulk Carriers Corp. Shs Par (SBLK)
Teck Resources CL B (TECK)
Vital Farms (VITL)
TJX Companies (TJX)
Fresh Del Monte Produce Ord (FDP)
Magnite Ord (MGNI)
Comcast Corp Cl A (CMCSA)

View all positions for GSA Capital Partners

Top funds holding Compass Therapeutics

OrbiMed Advisors
Blackstone Group
BlackRock
BlackRock
Rock Springs Capital Management
Henderson Group
MPM Oncology Impact Management
Vanguard Group
Blue Owl Capital Holdings
Geode Capital Management
Cormorant Asset Management
State Street Corporation
Tang Capital Management
Baker Bros. Advisors
Northern Trust

View all funds holding Compass Therapeutics